Of late, in order to develop safe and efficacious drugs for the treatment of T2DM, more and more researchers have focused on GLP-1 drugs represented by gastrointestinal hormone polypeptide drugs, such as semaglutide, exenatide, dulaglutide, albiglutide, etc. 6–9. Here, GLP1R is linked to type 2 diabetes mellitus.